Poseida Therapeutics Overview

Poseida Therapeutics EBIT

EBIT (Earnings Before Interest and Taxes) analysis for PSTX.

Quarterly EBIT

$19.74M

↑ 152.41% YoY

As of Sep 30, 2024

Annual EBIT (TTM)

-$77.23M

↑ 43.1% YoY

Trailing 12 months ending Sep 30, 2024

Average EBIT (Comparison Companies)

EBIT History

EBIT Comparison

Annual EBIT Growth Rate (%)

Annual EBIT Growth (Absolute)

Jump to metric

Total Revenue Cost of Revenue Gross Profit Research & Development Selling, General & Admin Operating Income Other Income Expense Net EBIT Income Tax Net Income Profit Margin